EUVIMEDOpdag EUVIMED
Crossref

Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition

Yun Wang, Jinling Wang iD, Roumei Ye, Quanyi Jin, Fengyue Yin, Nian Liu, Yubo Wang, Quan Zhang, Ting Gao, Yilin Zhao

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c00873 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2024. Written by Yun Wang and 9 co-authors. Institution: Department of Gastroenterology, Jiamusi Central Hospital, Jiamus 154003, P. R. China. Major MEDLINE topics: Ferrocyanides, Doxorubicin, Nanoparticles, Triazoles. Cited 12 times so far (Crossref); 50 references. Funded by: Natural Science Foundation of Xiamen Municipality, Xiamen Municipal Bureau of Science and Technology, Health Commission of Heilongjiang Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Combined mild-temperature photothermal/chemotherapy has emerged as a highly promising modality for tumor therapy. However, its therapeutic efficacy is drastically compromised by the heat-induced overexpression of heat shock proteins (HSPs) by the cells, which resist heat stress and apoptosis. The purpose of this study was to downregulate HSPs and enhance the mild-temperature photothermal/chemotherapy effect. In detail, the colon cancer cell membrane (CT26M)-camouflaged HSP90 inhibitor ganetespib and the chemotherapeutic agent doxorubicin (DOX)-coloaded hollow mesoporous Prussian blue (HMPB) nanoplatform (named PGDM) were designed for synergistic mild photothermal/chemotherapy via HSP inhibition. In addition to being a photothermal agent with a high efficiency of photothermal conversion (24.13%), HMPB offers a hollow hole that can be filled with drugs. Concurrently, the cancer cell membrane camouflaging enhances tumor accumulation through a homologous targeting mechanism and gives the nanoplatform the potential to evade the immune system. When exposed to NIR radiation, HMPB's photothermal action (44 °C) not only causes tumor cells to undergo apoptosis but also causes ganetespib to be released on demand. This inhibits the formation of HSP90, which enhances the mild photothermal/chemotherapy effect. The results confirmed that the combined treatment regimen of mild photothermal therapy (PTT) and chemotherapy showed a better therapeutic efficacy than the individual treatment methods. Therefore, this multimodal nanoparticle can advance the development of drugs for the treatment of malignancies, such as colon cancer, and has prospects for clinical application.

Subjects

MeSH terms (MEDLINE)

FerrocyanidesDoxorubicinNanoparticlesTriazolesAntineoplastic AgentsColonic NeoplasmsHeat-Shock ProteinsAnimalsMiceCell Line, TumorHumansApoptosisPhotothermal TherapyHSP90 Heat-Shock ProteinsPhototherapy

Author keywords

colon cancercombinational therapyheat shock proteinshomologous targetingmild photothermal therapy

Substances

ferric ferrocyanideFerrocyanidesDoxorubicinTriazolesAntineoplastic AgentsHSP90 Heat-Shock ProteinsSTA 9090Heat-Shock Proteins

Authors and institutions

  • Department of Gastroenterology, Jiamusi Central Hospital, Jiamus 154003, P. R. China.
  • Department of Internal Medicine, School of Clinical Medicine, Jiamusi University, Jiamusi 154007, P. R. China.
  • Department of Emergency and Critical Care Center, The Second Affiliated Hospital of Guangdong Medical University, No.12 Minyou Road, Xiashan, Zhanjiang, Guangdong 524003, P. R. China.
  • Department of Pharmacy, Medical College of Guangxi University, Nanning 530004, P. R. China.
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, P. R. China.
  • Department of Biomedical Engineering, Medical College of Guangxi University, Nanning 530004, P. R. China.

ORCID profiles: Jinling Wang

Funding

  • Natural Science Foundation of Xiamen Municipality
  • Xiamen Municipal Bureau of Science and Technology
  • Health Commission of Heilongjiang Province
  • Xiamen City

Cite

APA

Wang, Y., Wang, J., Ye, R., Jin, Q., Yin, F., Liu, N., Wang, Y., Zhang, Q., Gao, T., & Zhao, Y. (2024). Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c00873

Vancouver

Wang Y, Wang J, Ye R, Jin Q, Yin F, Liu N, et al. Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c00873

BibTeX
@article{Wang2024,
  author = {Wang, Yun and Wang, Jinling and Ye, Roumei and Jin, Quanyi and Yin, Fengyue and Liu, Nian and Wang, Yubo and Zhang, Quan and Gao, Ting and Zhao, Yilin},
  title = {Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c00873}
}
Start for free →